(posted 6th August 2019) Stephens Lawyers & Consultants have published an article which includes practical guidelines on steps that can be taken by businesses/companies to ensure that their AI generated works are protected by copyright. This is the…
2 August 2019 A Melbourne study supported by the Cerebral Palsy Alliance Research Foundation is following an exciting new lead that could help to protect newborn babies against cerebral palsy, the most common childhood disability in Australia. Platelets…
1 August 2019 The successful applicants for the first round of the Frontiers Program were announced in April this year, and attention has now turned to the next round which is anticipated to open in October. While the…
23 July 2019 As reported in Biotech Daily Exopharm says it is ready for a 20-patient phase I trial of its Plexaris exosomo treatment for would healing, and has requesting a trading halt for a capital raising. Exopharm…
23 July 2019 We were honoured and thrilled to have won the Webby Award with our amazing digital team Two Bulls. Webby Award, presented by The International Academy of Digital Arts and Sciences is described as “The Internet’s…
23 July 2019 June and July have been very productive months for Smileyscope, as interest in our product continues to grow in both Australia and the USA. Following our highly successful clinical trial publication in The Journal of…
22 July 2019 Adelaide, Australia: LBT Innovations Limited (ASX: LBT) (LBT or the Company), a leader in medical technology automation using artificial intelligence, is pleased to provide this update on recent activities related to the appointment of distributors…
18 July 2019 Planet Innovation took home the Good Design Awards’ top gong for medical design for our work on Clever Culture Systems’ APAS Independence instrument, along with a digital design award for Uniting NSW’s Mosaic app. Clever…
18 July 2019 More than a dozen research projects to better understand dementia will be given a total of $21 million in federal government funding. The 13 projects focus on risk reduction, prevention and tracking of dementia, the…
18 July 2019 As reported in Biotech Daily Imagion says the US Food and Drug Administration has granted ‘breakthrough device designation’ for its Magsense HER2 breast cancer staging test. Imagion said devices that provided a more effective treatment…
18 July 2019 As reported in Biotech Daily Sienna Chief Executive Officer Matthew Hoskin says the company is building a portfolio of in-vitro cancer diagnostic products to support researchers and laboratories. Mr Hoskin told Biotech Daily that with…
18 July 2019 (Nominations close – 27 September) Each year, the AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards are presented at the AusBiotech national conference to recognise the highest achievers in the Australian life sciences. From…